These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22339613)

  • 1. Antipsychotic-induced psychotic-like syndrome and pathological smiling in an adolescent.
    Burkey MD; Howell C; Riddle MA; Coffey BJ
    J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):92-5. PubMed ID: 22339613
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible ziprasidone-induced mania.
    Larson MF; Hauser A
    J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1012; discussion 1012-3. PubMed ID: 12964565
    [No Abstract]   [Full Text] [Related]  

  • 3. Advanced pediatric psychopharmacology.
    Vito J; Jummani R; Coffey B
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):498-502. PubMed ID: 16958576
    [No Abstract]   [Full Text] [Related]  

  • 4. Ziprasidone induced symptomatic bradycardia: a case report.
    Menon V; Kattimani S; Ayyanar S
    Aust N Z J Psychiatry; 2011 Sep; 45(9):789. PubMed ID: 21668298
    [No Abstract]   [Full Text] [Related]  

  • 5. Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease.
    Duggal HS; Singh I
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):583-4. PubMed ID: 18022304
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessments of suicidality in double-blind, placebo-controlled trials of ziprasidone.
    Karayal ON; Anway SD; Batzar E; Vanderburg DG
    J Clin Psychiatry; 2011 Mar; 72(3):367-75. PubMed ID: 21450154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.
    Montejo AL; Rico-Villademoros F;
    J Clin Psychopharmacol; 2008 Oct; 28(5):568-70. PubMed ID: 18794656
    [No Abstract]   [Full Text] [Related]  

  • 8. Sudden akathisia after a ziprasidone dose reduction.
    Oral ET; Altinbas K; Demirkiran S
    Am J Psychiatry; 2006 Mar; 163(3):546. PubMed ID: 16513883
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.
    Ekinci O; Sabuncuoglu O
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):648-9. PubMed ID: 21134409
    [No Abstract]   [Full Text] [Related]  

  • 10. Worsening schizoaffective disorder with aripiprazole.
    Reeves RR; Mack JE
    Am J Psychiatry; 2004 Jul; 161(7):1308. PubMed ID: 15229073
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience with ziprasidone.
    Patel NC; Sierk P; Dorson PG; Crismon L
    J Am Acad Child Adolesc Psychiatry; 2002 May; 41(5):495. PubMed ID: 12014778
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrocardiographic changes with ziprasidone.
    Loebel A; Miceli J; Chappell P; Siu C
    J Am Acad Child Adolesc Psychiatry; 2006 Jun; 45(6):636-637. PubMed ID: 16721311
    [No Abstract]   [Full Text] [Related]  

  • 13. A patient with multiple episodes of rhabdomyolysis induced by different neuroleptics.
    Aggarwal R; Guanci N; Marambage K; Caplan JP
    Psychosomatics; 2014; 55(4):404-408. PubMed ID: 24016383
    [No Abstract]   [Full Text] [Related]  

  • 14. Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone.
    Yang SH; McNeely MJ
    Am J Psychiatry; 2002 Aug; 159(8):1435. PubMed ID: 12153844
    [No Abstract]   [Full Text] [Related]  

  • 15. Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia.
    Saitis M; Papazisis G; Katsigiannopoulos K; Kouvelas D
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):624. PubMed ID: 18950388
    [No Abstract]   [Full Text] [Related]  

  • 16. Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone.
    Scahill L; Blair J; Leckman JF; Martin A
    J Psychopharmacol; 2005 Mar; 19(2):205-6. PubMed ID: 15728441
    [No Abstract]   [Full Text] [Related]  

  • 17. Ziprasidone in Parkinson's disease psychosis.
    Connemann BJ; Schönfeldt-Lecuona C
    Can J Psychiatry; 2004 Jan; 49(1):73. PubMed ID: 14763682
    [No Abstract]   [Full Text] [Related]  

  • 18. Tardive dystonia associated with ziprasidone.
    Papapetropoulos S; Wheeler S; Singer C
    Am J Psychiatry; 2005 Nov; 162(11):2191. PubMed ID: 16263868
    [No Abstract]   [Full Text] [Related]  

  • 19. Ziprasidone-induced oculogyric crisis.
    Ramos AE; Shytle RD; Silver AA; Sanberg PR
    J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1013-4. PubMed ID: 12964566
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical antipsychotic drug-induced acute laryngeal dystonia: 2 case reports.
    Mellacheruvu S; Norton JW; Schweinfurth J
    J Clin Psychopharmacol; 2007 Apr; 27(2):206-7. PubMed ID: 17414248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.